Partner Anna Dodson is featured in a Q&A with Accion discussing her new role as Board Chair for Accion’s U.S. Network and sharing her commitment to small businesses and her vision for the future.
Read the full article.
Related Content
- NewslettersNovember 1, 2025 - November 14, 2025
SEC’s Division of Corporation Finance Provides Post-Shutdown Guidance
- AlertNovember 3, 2025
Outnumbered, Not Outplayed: Minority Lenders Successfully Challenge Exclusive Backstop Agreement on Equal Treatment Grounds in ConvergeOne
- NewslettersOctober 17, 2025 – October 30, 2025
California Air Resources Board Posts Draft Scope 1 and 2 GHG Reporting Template
- NewslettersOctober 3, 2025 - October 16, 2025
SEC Chairman Vows to Make IPOs Great Again
- NewslettersSeptember 19, 2025 – October 2, 2025
SEC Guidance on Operations During the U.S. Federal Government Shutdown
- NewslettersSeptember 1, 2025 - September 18, 2025
SEC Publishes Spring 2025 Regulatory (and Deregulatory) Agenda
- InsightSeptember 4, 2025
Incentivizing Executives to Stay Through a Chapter 11 Asset Sale (Part I): Key Employee Retention Programs for Insiders
- NewslettersAugust 1, 2025 - August 28, 2025
SEC Introduces Capital Markets Data Visualizations Page
- Awards and RankingsNovember 25, 2025
Goodwin Named to Global Restructuring Review’s GRR 100 for the Fifth Consecutive Year
- Awards and RankingsNovember 6, 2025
Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas
- Awards and RankingsOctober 16, 2025
Chambers UK 2026 Highly Ranks Goodwin UK’s Platform
- Awards and RankingsOctober 1, 2025
The Legal 500 UK 2026 Highly Ranks Goodwin’s UK Platform
- Press ReleaseAugust 4, 2025
Goodwin Selected as Counsel to Official Committee of Unsecured Creditors in Alachua Government Services Chapter 11 Bankruptcy Case
- Awards and RankingsJune 11, 2025
The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers
- Press ReleaseMay 19, 2025
23andMe Enters into Asset Purchase Agreement to be Acquired by Regeneron for $256 Million
- Press ReleaseMay 1, 2025
Kronos Bio To Be Taken Private by Concentra Biosciences